P-Cure shared a post on Facebook:
“Respiratory motion during breathing makes lung tumors difficult to target accurately. ARC proton therapy delivers a continuous, conformal dose while accounting for this motion, minimizing exposure to healthy lung tissue.
Want to find out more about our technology?
Contact us at: info@p-cure.com.”

For more updates, follow OncoDaily.